Therapeutic effects of bezafibrate in hyperlipidemia
Kunesová, M.; Honková, M.; Zeman, M.; Mares, P.; Skorepa, J.
Casopis Lekaru Ceskych 122(20): 628-631
1983
ISSN/ISBN: 0008-7335 PMID: 6342789 Document Number: 202583
Document emailed within 1 workday
Related Documents
Vílchez Joya, R.; Escobar Jiménez, F.; Campos, M.M.; Torres, E.; Orduña, R.; Cabrera, J.; Núñez, J. 1986: Effects of bezafibrate in patients with combined hyperlipidemia Medicina Clinica 86(5): 190-194Hamada, Y.; Fukagawa, M. 2008: Relationship between lipid and glucose metabolism and bone mineral metabolism : pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia Clinical Calcium 18(5): 671-676
Adam, O.; Wolfram, G.; Lang, P.D.; Zöllner, N. 1979: Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia Münchener Medizinische Wochenschrift 121(9): 319-322
Sznajderman, M. 1984: Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV Przeglad Lekarski 41(7): 493-499
Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187
Hirschfield, G. 2001: Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study)--a rebuttal Thrombosis and Haemostasis 85(1): 189-190
Zhao, G.; Dai, Y.; Wang, Y. 1995: Effects of coconut juice on the formation of hyperlipidemia and atherosclerosis Zhonghua Yu Fang Yi Xue Za Zhi 29(4): 216-218
Zhou, L.; Wan, W.-j.; Liu, L.-g.; Li, X.; Zhang, H.-x.; Zhang, T.-f. 2008: Effects of electroacupuncture at "Fenglong" (ST 40) on NO, ET and CGRP levels in the rat with hyperlipidemia Zhongguo Zhen Jiu 28(1): 57-60
Büyükçelik, M.; Anarat, A.; Bayazit, A.K.; Noyan, A.ül.; Ozel, A.; Anarat, R.ük.; Aydingülü, H.; Dikmen, N. 2002: The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome Turkish Journal of Pediatrics 44(1): 40-44
Okopień, B.ła.; Cwalina, Łu.; Haberka, M.; Kowalski, J.; Zieliński, M.; Szwed, Z.; Kalina, Z.; Herman, Z.S. 2002: Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(78): 465-469
Chongviriyaphan, N.; Tapaneya-Olarn, C.; Suthutvoravut, U.; Karnchanachumpol, S.; Chantraruksa, V. 1999: Effects of tuna fish oil on hyperlipidemia and proteinuria in childhood nephrotic syndrome Journal of the Medical Association of Thailand 82(Suppl 1): S122-S128
Yu, H.; Wang, J.; Li, Y. 2004: Effects of turtle egg powder mixture on serum lipids of experimental hyperlipidemia rats Wei Sheng Yan Jiu 33(1): 91-93
Zhang, H.-F.; Wang, L.-L.; Ji, M.-Y.; Zhou, X.-Y. 2013: Effects of mild moxibustion on contents of blood lipoids and serum NO in hyperlipidemia rats Zhongguo Zhen Jiu 33(5): 438-442
Toleikis, P.M.; Godin, D.V. 1993: The effects of stress on plasma lipids and antioxidant status in rats with diet induced hyperlipidemia Proceedings of the Western Pharmacology Society 36: 149-155
Kleinau, H.; Wilhelm, R. 1981: Prophylactic and therapeutic intermittent positive pressure breathing with combined therapeutic aerosols (IPPB/I)--functional and morphological effects. II. Therapeutic IPPB/I in ventilation disturbances of the lung Zeitschrift für Erkrankungen der Atmungsorgane 156(2): 151-158
McCune, T.R.; Thacker LR, I.I.; Peters, T.G.; Mulloy, L.; Rohr, M.S.; Adams, P.A.; Yium, J.; Light, J.A.; Pruett, T.; Gaber, A.O.; Selman, S.H.; Jonsson, J.; Hayes, J.M.; Wright, F.H.; Armata, T.; Blanton, J.; Burdick, J.F. 1998: Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study Transplantation 65(1): 87-92
Lata, S.; Saxena, K.K.; Bhasin, V.; Saxena, R.S.; Kumar, A.; Srivastava, V.K. 1991: Beneficial effects of Allium sativum, Allium cepa and Commiphora mukul on experimental hyperlipidemia and atherosclerosis--a comparative evaluation Journal of Postgraduate Medicine 37(3): 132-135
Smith, D.H.; Neutel, J.M.; Jankelow, D.; Myburgh, D.P. 1990: Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia South African Medical Journal 77(10): 500-503
Inoue, M.; Jimi, T.; Machida, H.; Niwa, Y.; Wakayama, Y. 1992: Bezafibrate myopathy in two patients with chronic renal failure Rinsho Shinkeigaku 32(7): 725-728
Borowska, A.; Bachórzewska-Gajewska, H.; Kaliciński, A. 1986: Platelet aggregation in patients with hyperlipoproteinemia treated with bezafibrate Polski Tygodnik Lekarski 41(9): 273-276